Sales in the global Radiation-Induced Myelosuppression Treatment Market are slated to total USD 2.9 Billion in 2022. Expanding at a steady 3.1% CAGR, the market valuation is projected to top USD 3.5 Billion in 2028.
| Attribute | Details |
|---|---|
| Radiation-Induced Myelosuppression Treatment Estimated Market Size 2022 | USD 2.9 Billion |
| Radiation-Induced Myelosuppression Treatment Market Value-based CAGR (2022 to 2028) | 3.1% |
| Radiation-Induced Myelosuppression Treatment Market Projected Size in 2028 | USD 3.5 Billion |
Increasing incidence of cancer worldwide is underpinning the need for advanced cancer treatment options and therapies. Early diagnosis and the availability of radiotherapy and chemotherapy are expected to fuel sales in the market through 2031.
In addition to this, the introduction of adjuvant therapy for cancer is playing a vital role in reducing the death rate of cancer, improving disease management, and the overall quality of life in cancer patients. As per Future Market Insights, the market is projected to expand on the back of the aforementioned factors over the forecast period.
| Particulars | Details |
|---|---|
| H1, 2021 | 3.42% |
| H1, 2022 Projected | 3.12% |
| H1, 2022 Outlook | 2.62% |
| BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 50 ↓ |
| BPS Change - H1, 2022 (O) - H1, 2021 | (-) 80 ↓ |
Future Market Insights presents a comparative analysis about the market growth rates and development prospects in the global market. According to FMI analysis, the radiation-induced myelosuppression treatment market is expected to drop by 80 Basis Point Share (BPS) in H1- 2022 compared to H1-2021.
However, BPS change of only 50 BPS was observed when comparing H1-2022 Outlook and H1-2022 Projected growth. Key reason for this dip in BPS is attributed to the factor such as stringent government regulations and approval process for pipeline products, which impacted the growth of the market.
However, some positive factors which will influence the market growth in future include new developments and introduction of novel therapeutics for treatment of radiation induced myelosuppression. For instance, on Feb 2021, FDA approved trilaciclib (Cosela, G1 Therapeutics) for lowering the rate of chemotherapy-induced myelosuppression (CIM) in adult patients suffering from extensive-stage small-cell lung cancer (ES-SCLC).
Demand in the radiation-induced myelosuppression treatment market is projected to increase at a 3.1% CAGR, in comparison to the 3.4% CAGR registered between 2013 to 2031.
The availability of various growth factors and favorable treatment guidelines have made the management of neutropenia easier. However, thrombocytopenia and anemia are still posing a burden on the healthcare system.
Thrombocytopenia can be managed with the help of available growth factors, but most of them are off-label. The management of anemia remains a challenge for cancer patients who receive radiation therapy for cancer treatment.
Due to changes in reimbursement and labeling of medications for anemia, the use of off-label indication erythropoietin-stimulating agents has decreased to an extent. This has resulted in growing need for blood transfusion, which is associated with various risk factors.
This, in turn, is underscoring the significance of myelosuppression treatment therapeutics and drugs, which is expected to boost the market over the assessment period.
Anemia is a common consequence of chronic kidney diseases (CKD) and radiation-induced myelosuppression. Due to the insufficiency of erythropoietin synthesis, patients suffer from anemia. However, the combination of erythropoiesis-stimulating agents (ESA) and iron has become a standard treatment for anemia.
ESAs effectively increase the hemoglobin (Hb) levels in patients. However, their use has been associated with increased cardiovascular risk, especially due to high dose intake in inflamed and hyporesponsive patients.
Iron deficiency is another consequence of anemia. This has resulted in the introduction of intravenous iron therapy which is beneficial for anemic patients, CKD patients, and patients dealing with heart failure.
A new class of drugs, namely prolyl hydroxylase domain (PHD) inhibitors is now available for the treatment of anemia. These drugs effectively stimulate the synthesis of endogenous erythropoietin and increase iron availability.
In addition to this, in February, the USA Food and Drug Administration (FDA)approved Cosela (Trilaciclib) as the first line of treatment in its class to reduce the frequency of bone marrow suppression in adults, which is caused by chemotherapy for the extensive stage.
Such developments are expected to provide impetus to the growth of the market over the assessment period, opines FMI.
High Prevalence of Chemotherapy Induced Myelosuppression Will Spur Demand in the USA
The USA is expected to dominate the North America radiation-induced myelosuppression treatment market owing to growing incidence of cancer, chronic kidney diseases (CKD), and patients dealing with heart failure.
The presence of leading market players and fast-tracked approvals by the FDA are expected to augment the growth of the USA market. In addition to this, the USA is home to a vast healthcare sector, which is expected to provide opportunities for growth to market players over the assessment period.
Healthcare Providers are Prescribing Myelosuppressive Chemotherapy Drugs To improve Bone Marrow Function
China is expected to account for a lion’s share of the East Asia radiation-induced myelosuppression treatment market. Increasing geriatric population in the country, along with high incidence of cancer and heart failure are spurring the demand for myelosuppression treatment drugs.
Further, increasing research and development activities for the development of iron deficiency treatment is expected to augment the growth of the market. Iron deficiency is a consequence of anemia caused by chemotherapy radiation.
Growing preference for erythropoiesis-stimulating agents (ESAs) for iron deficiency in the country is anticipated to boost the market in the forthcoming years.
Surging Trend of Medical Tourism Will Boost Sales of Myelosuppression Chemotherapy Drugs
The UK is expected to emerge as a lucrative pocket in the Europe radiation-induced myelosuppression treatment market owing to the influx of medical tourists in the country, along with the availability of superior healthcare facilities.
Increasing adoption of technologically advanced medical equipment for the treatment of various chronic disorders such and cancer and kidney failure in the country is expected to augment the growth of the market in the forthcoming years.
Further, rising awareness regarding adjuvant treatment for cancer in the UK will continue boosting the market over the assessment period.
Surging Incidence of Neutropenia to Drive Preference for Myelosuppression Treatment Regimen
Based on indication, sales in the neutropenia segment are projected to account for 43.3% of the total market share in 2022. Neutropenia is a condition where an individual deals with abnormally low counts of white blood cells.
Bone marrow malfunction caused by chemotherapy radiations is a chief factor driving sales in this segment. Lack of white blood cells in patients weakens the immune system and their ability to fight infections, which makes it imperative to seek treatment for the same.
Owing to the aforementioned factors, sales in this segment are projected to increase at a considerable pace over the assessment period.
Rising Awareness Regarding New Erythropoietin Stimulating Agents Will Bolster Sales
In terms of drug class, demand in the erythropoietin stimulating agents (ESA) segment is projected to remain high over the assessment period. ESAs effectively improve the efficacy of iron therapy in anemic patients after chemotherapy radiations, which is expected to continue pushing sales in the market.
Besides this, growing preference for intravenous iron therapy with a combination of ESAs is expected to complement the growth of the market in the forthcoming years. The combination of ESAs and IV iron therapy improve the red blood cells count as compared to other treatment using ESAs alone.
Sales of Myelosuppression Chemotherapy Drugs to Remain High Via Hospital Pharmacies
Based on the sales channel, sales in the hospital pharmacies segment are projected to increase at a considerable pace owing to the wide availability of therapeutic drugs in these shops. However, high convenience and timely delivery offered by online pharmacies will place them as a lucrative segment over the assessment period.
Oral Route of Administration for Myelosuppression Chemotherapy Medication to Gain Traction
In terms of route of administration, the oral route is expected to be preferred by both healthcare professionals and patients owing to ease of administration and high efficacy. Growing preference for non-invasive treatment options will also provide impetus to sales in this segment.
Leading players operating in the global radiation-induced myelosuppression treatment market are investing in research and development to improve lines of treatment for myelosuppression treatment. In addition to this, players are investing in mergers and acquisitions to strengthen their distribution channels.
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2028 |
| Historical Data Available for | 2013 to 2021 |
| Market Analysis | Units for Volume and USD Million for Value |
| Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania, and MEA |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Nordic, Russia, Poland, China, India, Thailand, Indonesia, Australia and New Zealand, Japan, GCC countries, North Africa, South Africa, others. |
| Key Market Segments Covered | Indication, Drug Class, Route of Administration, Distribution Channel, and Region |
| Key Companies Profiled | Amgen Inc.; Novartis AG; Teva Pharmaceutical Industries Ltd; Mylan N.V.; Pfizer Inc.; Janssen Global Services, LLC (Johnson & Johnson); Partner Therapeutics, Inc.; Mission Pharmacal Company; Myelo Therapeutics GmbH; Pluristem Therapeutics Inc. |
| Pricing | Available upon Request |
Table 1: Radiation Induced Myelosuppression Treatment Market Pipeline Analysis (2021)
Table 2: North America Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 3: North America Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Drug Class
Table 4: North America Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route of Administration
Table 5: North America Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Indication
Table 6: North America Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel
Table 7: Latin America Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 8: Latin America Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Drug Class
Table 9: Latin America Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route of Administration
Table 10:Latin America Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Indication
Table 11:Latin America Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel
Table 12:Western Europe Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 13:Western Europe Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Drug Class
Table 14:Western Europe Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route of Administration
Table 15:Western Europe Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Indication
Table 16:Western Europe Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel
Table 17:Eastern Europe Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 18:Eastern Europe Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Drug Class
Table 19:Eastern Europe Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route of Administration
Table 20:Eastern Europe Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Indication
Table 21:Eastern Europe Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel
Table 22:APEJ Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 23:APEJ Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Drug Class
Table 24:APEJ Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route of Administration
Table 25:APEJ Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Indication
Table 26:APEJ Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel
Table 27:Japan Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Drug Class
Table 28:Japan Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route of Administration
Table 29:Japan Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Indication
Table 30:Japan Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel
Table 31:MEA Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 32:MEA Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Drug Class
Table 33:MEA Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route of Administration
Table 34:MEA Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Indication
Table 35:MEA Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel
Table 36:Global Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Region
Table 37:Global Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Indication
Table 38:Global Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route of Administration
Table 39:Global Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channe
Figure 01: Clinical Programs for Radiation Induced Myelosuppression Treatment, by Indication
Figure 02: Clinical Programs for Radiation Induced Myelosuppression Treatment, by Phase
Figure 03: Global Radiation Induced Myelosuppression Treatment Market Absolute $ Opportunity, 2013–2028
Figure 04: Global Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis, 2013–2021
Figure 05: Global Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 06: North America Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis, 2013–2021
Figure 07: North America Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 08: North America Radiation Induced Myelosuppression Treatment Market Analysis by Country –2022 & 2028
Figure 09: North America Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Country, 2022 – 2028
Figure 10: North America Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Country, 2022 – 2028
Figure 11: North America Radiation Induced Myelosuppression Treatment Market Analysis by Type–2022 & 2028
Figure 12: North America Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Type, 2022 – 2028
Figure 13: North America Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Type, 2022 – 2028
Figure 14: North America Radiation Induced Myelosuppression Treatment Market Analysis by Indication – 2022 & 2028
Figure 15: North America Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Indication, 2022 – 2028
Figure 16: North America Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Indication, 2022 – 2028
Figure 17: North America Radiation Induced Myelosuppression Treatment Market Analysis by Indication – 2022 & 2028
Figure 18: North America Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Indication, 2022 – 2028
Figure 19: North America Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Indication, 2022 – 2028
Figure 20: North America Radiation Induced Myelosuppression Treatment Market Analysis by Distribution Channel – 2022 & 2028
Figure 21: North America Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Distribution Channel, 2022 – 2028
Figure 22: North America Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Distribution Channel, 2022 – 2028
Figure 23: Latin America Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis, 2013–2021
Figure 24: Latin America Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 25: Latin America Radiation Induced Myelosuppression Treatment Market Analysis by Country –2022 & 2028
Figure 26: Latin America Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Country, 2022 – 2028
Figure 27: Latin America Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Country, 2022 – 2028
Figure 28: Latin America Radiation Induced Myelosuppression Treatment Market Analysis by Type–2022 & 2028
Figure 29: Latin America Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Type, 2022 – 2028
Figure 30: Latin America Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Type, 2022 – 2028
Figure 31: Latin America Radiation Induced Myelosuppression Treatment Market Analysis by Indication – 2022 & 2028
Figure 32: Latin America Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Indication, 2022 – 2028
Figure 33: Latin America Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Indication, 2022 – 2028
Figure 34: Latin America Radiation Induced Myelosuppression Treatment Market Analysis by Indication – 2022 & 2028
Figure 35: Latin America Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Indication, 2022 – 2028
Figure 36: Latin America Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Indication, 2022 – 2028
Figure 37: Latin America Radiation Induced Myelosuppression Treatment Market Analysis by Distribution Channel – 2022 & 2028
Figure 38: Latin America Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Distribution Channel, 2022 – 2028
Figure 39: Latin America Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Distribution Channel, 2022 – 2028
Figure 40: Western Europe Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis, 2013–2021
Figure 41: Western Europe Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 42: Western Europe Radiation Induced Myelosuppression Treatment Market Analysis by Country –2022 & 2028
Figure 43: Western Europe Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Country, 2022 – 2028
Figure 44: Western Europe Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Country, 2022 – 2028
Figure 45: Western Europe Radiation Induced Myelosuppression Treatment Market Analysis by Type–2022 & 2028
Figure 46: Western Europe Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Type, 2022 – 2028
Figure 47: Western Europe Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Type, 2022 – 2028
Figure 48: Western Europe Radiation Induced Myelosuppression Treatment Market Analysis by Indication – 2022 & 2028
Figure 49: Western Europe Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Indication, 2022 – 2028
Figure 50: Western Europe Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Indication, 2022 – 2028
Figure 51: Western Europe Radiation Induced Myelosuppression Treatment Market Analysis by Indication – 2022 & 2028
Figure 52: Western Europe Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Indication, 2022 – 2028
Figure 53: Western Europe Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Indication, 2022 – 2028
Figure 54: Western Europe Radiation Induced Myelosuppression Treatment Market Analysis by Distribution Channel – 2022 & 2028
Figure 55: Western Europe Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Distribution Channel, 2022 – 2028
Figure 56: Western Europe Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Distribution Channel, 2022 – 2028
Figure 57: Eastern Europe Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis, 2013–2021
Figure 58: Eastern Europe Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 59: Eastern Europe Radiation Induced Myelosuppression Treatment Market Analysis by Country –2022 & 2028
Figure 60: Eastern Europe Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Country, 2022 – 2028
Figure 61: Eastern Europe Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Country, 2022 – 2028
Figure 62: Eastern Europe Radiation Induced Myelosuppression Treatment Market Analysis by Type–2022 & 2028
Figure 63: Eastern Europe Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Type, 2022 – 2028
Figure 64: Eastern Europe Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Type, 2022 – 2028
Figure 65: Eastern Europe Radiation Induced Myelosuppression Treatment Market Analysis by Indication – 2022 & 2028
Figure 66: Eastern Europe Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Indication, 2022 – 2028
Figure 67: Eastern Europe Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Indication, 2022 – 2028
Figure 68: Eastern Europe Radiation Induced Myelosuppression Treatment Market Analysis by Indication – 2022 & 2028
Figure 69: Eastern Europe Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Indication, 2022 – 2028
Figure 70: Eastern Europe Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Indication, 2022 – 2028
Figure 71: Eastern Europe Radiation Induced Myelosuppression Treatment Market Analysis by Distribution Channel – 2022 & 2028
Figure 72: Eastern Europe Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Distribution Channel, 2022 – 2028
Figure 73: Eastern Europe Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Distribution Channel, 2022 – 2028
Figure 74: APEJ Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis, 2013–2021
Figure 75: APEJ Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 76: APEJ Radiation Induced Myelosuppression Treatment Market Analysis by Country –2022 & 2028
Figure 77: APEJ Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Country, 2022 – 2028
Figure 78: APEJ Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Country, 2022 – 2028
Figure 79: APEJ Radiation Induced Myelosuppression Treatment Market Analysis by Type–2022 & 2028
Figure 80: APEJ Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Type, 2022 – 2028
Figure 81: APEJ Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Type, 2022 – 2028
Figure 82: APEJ Radiation Induced Myelosuppression Treatment Market Analysis by Indication – 2022 & 2028
Figure 83: APEJ Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Indication, 2022 – 2028
Figure 84: APEJ Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Indication, 2022 – 2028
Figure 85: APEJ Radiation Induced Myelosuppression Treatment Market Analysis by Indication – 2022 & 2028
Figure 86: APEJ Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Indication, 2022 – 2028
Figure 87: APEJ Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Indication, 2022 – 2028
Figure 88: APEJ Radiation Induced Myelosuppression Treatment Market Analysis by Distribution Channel – 2022 & 2028
Figure 89: APEJ Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Distribution Channel, 2022 – 2028
Figure 90: APEJ Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Distribution Channel, 2022 – 2028
Figure 91: Japan Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis, 2013–2021
Figure 92: Japan Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 93: Japan Radiation Induced Myelosuppression Treatment Market Analysis by Type–2022 & 2028
Figure 94: Japan Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Type, 2022 – 2028
Figure 95: Japan Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Type, 2022 – 2028
Figure 96: Japan Radiation Induced Myelosuppression Treatment Market Analysis by Indication – 2022 & 2028
Figure 97: Japan Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Indication, 2022 – 2028
Figure 98: Japan Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Indication, 2022 – 2028
Figure 99: Japan Radiation Induced Myelosuppression Treatment Market Analysis by Indication – 2022 & 2028
Figure 100:Japan Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Indication, 2022 – 2028
Figure 101:Japan Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Indication, 2022 – 2028
Figure 102:Japan Radiation Induced Myelosuppression Treatment Market Analysis by Distribution Channel – 2022 & 2028
Figure 103:Japan Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Distribution Channel, 2022 – 2028
Figure 104:Japan Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Distribution Channel, 2022 – 2028
Figure 105:MEA Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis, 2013–2021
Figure 106:MEA Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 107:MEA Radiation Induced Myelosuppression Treatment Market Analysis by Country –2022 & 2028
Figure 108:MEA Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Country, 2022 – 2028
Figure 109:MEA Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Country, 2022 – 2028
Figure 110:MEA Radiation Induced Myelosuppression Treatment Market Analysis by Type–2022 & 2028
Figure 111:MEA Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Type, 2022 – 2028
Figure 112:MEA Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Type, 2022 – 2028
Figure 113:MEA Radiation Induced Myelosuppression Treatment Market Analysis by Indication – 2022 & 2028
Figure 114:MEA Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Indication, 2022 – 2028
Figure 115:MEA Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Indication, 2022 – 2028
Figure 116:MEA Radiation Induced Myelosuppression Treatment Market Analysis by Indication – 2022 & 2028
Figure 117:MEA Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Indication, 2022 – 2028
Figure 118:MEA Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Indication, 2022 – 2028
Figure 119:MEA Radiation Induced Myelosuppression Treatment Market Analysis by Distribution Channel – 2022 & 2028
Figure 120:MEA Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Distribution Channel, 2022 – 2028
Figure 121:MEA Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Distribution Channel, 2022 – 2028
Figure 122:Global Radiation Induced Myelosuppression Treatment Market Analysis by Region –2022 & 2028
Figure 123:Global Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Region, 2022 – 2028
Figure 124:Global Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Region
Figure 125:Global Radiation Induced Myelosuppression Treatment Market Analysis by Indication–2022 & 2028
Figure 126:Global Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Indication, 2022 – 2028
Figure 127:Global Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Indication
Figure 128:Global Radiation Induced Myelosuppression Treatment Market Analysis by Route of Administration –2022 & 2028
Figure 129:Global Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Route of Administration, 2022 – 2028
Figure 130:Global Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route of Administration
Figure 131:Global Radiation Induced Myelosuppression Treatment Market Analysis by Distribution Channel–2022 & 2028
Figure 132:Global Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Distribution Channel, 2022 – 2028
Figure 133:Global Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel
The global radiation-induced myelosuppression treatment market is expected to reach a valuation of USD 2.9 Billion in 2022.
The global Radiation-induced myelosuppression treatment market grew at a 3.4% CAGR between 2013 and 2021.
Increasing preference for non-invasive drug administration, along with the introduction of intravenous iron therapy are key trends driving radiation-induced myelosuppression treatment sales.
North America is projected to account for a dominant share of the global radiation-induced myelosuppression treatment market share during the forecast period.
The radiation-induced myelosuppression treatment market in Europe is anticipated to expand at a considerable pace over the assessment period.
Explore Similar Insights
Radiation-Induced Myelosuppression Treatment Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
